DE3041368A1 - Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung - Google Patents

Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung

Info

Publication number
DE3041368A1
DE3041368A1 DE19803041368 DE3041368A DE3041368A1 DE 3041368 A1 DE3041368 A1 DE 3041368A1 DE 19803041368 DE19803041368 DE 19803041368 DE 3041368 A DE3041368 A DE 3041368A DE 3041368 A1 DE3041368 A1 DE 3041368A1
Authority
DE
Germany
Prior art keywords
injection solutions
general formula
solvent mixtures
preparation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803041368
Other languages
German (de)
English (en)
Inventor
Dipl.-Pharm. Dr. Budapest Gazdag
Dipl.-Pharm. Dr. Geza Takacsi Nagy
Dipl.-Pharm. Dipl.-Ing.-Chem. Dr. Gabor Szepesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE3041368A1 publication Critical patent/DE3041368A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19803041368 1979-11-02 1980-11-03 Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung Withdrawn DE3041368A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application

Publications (1)

Publication Number Publication Date
DE3041368A1 true DE3041368A1 (de) 1981-05-14

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803041368 Withdrawn DE3041368A1 (de) 1979-11-02 1980-11-03 Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung

Country Status (24)

Country Link
US (1) US4344950A (OSRAM)
JP (1) JPS56123911A (OSRAM)
AR (1) AR223735A1 (OSRAM)
AT (1) AT377914B (OSRAM)
AU (1) AU533715B2 (OSRAM)
BE (1) BE885987A (OSRAM)
CA (1) CA1159367A (OSRAM)
CH (1) CH645019A5 (OSRAM)
CS (1) CS226417B2 (OSRAM)
DD (1) DD153760A5 (OSRAM)
DE (1) DE3041368A1 (OSRAM)
DK (1) DK464680A (OSRAM)
FI (1) FI803401L (OSRAM)
FR (1) FR2468373A1 (OSRAM)
GB (1) GB2062464B (OSRAM)
HU (1) HU181940B (OSRAM)
IL (1) IL61310A (OSRAM)
IT (1) IT1209367B (OSRAM)
NL (1) NL8005980A (OSRAM)
NO (1) NO803254L (OSRAM)
PH (1) PH17037A (OSRAM)
SE (1) SE8007569L (OSRAM)
YU (1) YU278880A (OSRAM)
ZA (1) ZA806468B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891B1 (OSRAM) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
CS226417B2 (en) 1984-03-19
IL61310A0 (en) 1980-12-31
GB2062464A (en) 1981-05-28
FR2468373A1 (fr) 1981-05-08
DK464680A (da) 1981-05-03
ZA806468B (en) 1981-10-28
BE885987A (fr) 1981-02-16
FI803401A7 (fi) 1981-05-03
IT8025683A0 (it) 1980-10-31
CH645019A5 (de) 1984-09-14
SE8007569L (sv) 1981-05-03
HU181940B (en) 1983-11-28
JPS56123911A (en) 1981-09-29
IL61310A (en) 1984-08-31
DD153760A5 (de) 1982-02-03
FI803401L (fi) 1981-05-03
PH17037A (en) 1984-05-17
US4344950A (en) 1982-08-17
YU278880A (en) 1984-04-30
AR223735A1 (es) 1981-09-15
FR2468373B1 (OSRAM) 1984-12-28
AT377914B (de) 1985-05-28
GB2062464B (en) 1983-12-07
CA1159367A (en) 1983-12-27
NL8005980A (nl) 1981-06-01
NO803254L (no) 1981-05-04
ATA527980A (de) 1984-10-15
AU6400480A (en) 1981-05-07
IT1209367B (it) 1989-07-16
AU533715B2 (en) 1983-12-08

Similar Documents

Publication Publication Date Title
DE69627651T2 (de) Formulierungen und zusammensetzungen von in wasser schwer löslichen camptothecinderivaten
EP0136470B1 (de) Injizierbare Lösung zur Behandlung von Entzündungen
DE2817335B2 (de) Stabiles Antibiotisches tetracyclinhaltiges Mittel
EP0049852B1 (de) Pharmazeutisches Präparat und seine Herstellung
DE2343657A1 (de) Neuer ester eines eckige klammer auf (methylamino)methyl eckige klammer zu benzyl-alkohols
DE4139017C2 (de) Wäßrige Piroxicam-Lösungen und Verfahren zu ihrer Herstellung
DE3042332A1 (de) Waessrige nitroglycerinloesung
DE60132798T2 (de) Zusammensetzung einer natriumkanal-blockierenden verbindung
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
DE3530046A1 (de) Aethylendiaminmonoamid-derivate
DE3041368A1 (de) Loesungsmittelgemische zur herstellung von parenteralverabreichbaren stabilen injektionsloesungen und deren verwendung
DE69703994T2 (de) Parenteral injizierbare Lösungen enthaltend Piroxicam
DE69016087T2 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE112016001715T5 (de) Stabile flüssige pharmazeutische Zusammensetzungen von Bortezomib
DE3751589T2 (de) Anthracyclin-Glucosid enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs.
DE69715247T2 (de) Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung
DE1467749A1 (de) Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten
EP1009410A1 (de) Verfahren zum herstellen von stabilen acetylsalicylsäure-lösungen
DE3011274A1 (de) Synergistische strahlenschuetzende pharmazeutische praeparate sowie deren herstellung
DE1231847B (de) Verfahren zur Herstellung von parenteral applizierbaren waessrigen Loesungen von substituierten Benzochinonen
DE3701461C2 (OSRAM)
EP1807112B1 (de) Stabile wässrige formulierungen eines platin derivats
CH656533A5 (de) Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
DE3537839C2 (OSRAM)

Legal Events

Date Code Title Description
8180 Miscellaneous part 1

Free format text: DIE BEZEICHNUNG LAUTET RICHTIG: LOESUNGSMITTELGEMISCHE ZUR HERSTELLUNG VON PARENTERAL VERABREICHBAREN STABILEN IJEKTIONSLOESUNGEN UND DEREN VERWENDUNG

8181 Inventor (new situation)

Free format text: NAGY, GEZA TAKACSI, DIPL.-PHARM. DR. SZEPESI, GABOR,DIPL.-PHARM.DIPL.-ING.-CHEM. GAZDAG, MARIA, DIPL.-PHARM. DR., BUDAPEST, HU

8130 Withdrawal